Ignite Creation Date:
2024-05-06 @ 4:00 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04830267
Status:
RECRUITING
Last Update Posted:
2024-03-28
First Post:
2021-03-31
Brief Title:
The Efficacy of Camrelizumab Plus Stereotactic Body Radiotherapy in RM NPC
Sponsor:
Chongqing University Cancer Hospital
Organization:
Chongqing University Cancer Hospital
Organization Data
Organization:
Chongqing University Cancer Hospital
Class:
OTHER
Study ID:
Camresbrt
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chongqing University Cancer Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Ying Wang
Responsible Party Title:
Associate Director of Chongqing University Cancer Hospital
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Chongqing University Cancer Hospital
Old Name:
None
Old Organization:
None